The treatment of calcified below-the-knee (BTK) lesions is challenging, associated with sub-optimal procedural outcomes, resulting in early recoil, and may contribute to restenosis.
Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
The treatment of calcified below-the-knee (BTK) lesions is challenging, associated with sub-optimal procedural outcomes, resulting in early recoil, and may contribute to restenosis.
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Cases, PAD Applications - BTK, PAD Applications - CLI, Peripheral Clinical Data
Following the excitement of the PAD III RCT results presented at VIVA in November, a rock star faculty of Prof. Gunnar Tepe, Prof. Thomas Zeller, Dr. Arne Schwindt and Dr. Lorenzo Patrone assembled for an incathlab session to discuss the study results and how IVL offers superior vessel preparation over conventional PTA in severely calcified PAD lesions.
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Clinical Data
At the recent PCR Valves eCourse (aka London Valves), an esteemed faculty reported on the use of IVL- facilitated TAVI. Profs./Drs. Carlo Di Mario, Ole De Backer, Joachim Schofer, Constantin von zur Mühlen used published data and case experiences to illustrate the advantages of using IVL to maintain transfemoral access in TAVI patients with severely calcified iliacs. Considering the importance of reducing complications to minimize hospital stay, the faculty expressed enthusiasm when considering the use of IVL in these very complex patients. Happy viewing!
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Clinical Data
In life, and when treating patients, we all prefer things to be less complicated. Unfortunately, treating peripheral vascular calcification is typically associated with suboptimal vessel expansion and an increased risk of complications.
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Clinical Data
In DISRUPT PAD III, we included the complex, torturous, calcified lesions and risky patients that other studies avoid. Review the results for yourself and see what superior looks like.
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Clinical Data
Iliac artery calcium is particularly difficult to manage both safely and effectively with most endovascular tools and often requires costly and risky adjunctive procedures or surgical intervention, increasing morbidity and cost.
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Clinical Data
The COVID-19 pandemic has brought a significant focus on important clinical and economic factors such as hospital length-of-stay and hospital resource utilization. Hospitals have been forced to innovate in order to maximize the availability of these resources while treating critical patients.
Topics: Peripheral IVL, DISRUPT PAD, PAD Applications - TAVR Access, PAD Applications - BTK, PAD Applications - CLI, Peripheral Clinical Data, PAD Applications - EVAR
Intravascular Lithotripsy (IVL) has been used and studied across all peripheral vessels, with multiple published studies in CFA, SFA, Popliteal and Infrapopliteal arteries.
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Clinical Data
Acute recoil is a phenomenon in small arteries, such as those below-the-knee (BTK), when there is a significant reduction in luminal gain within just a few minutes after balloon angioplasty. Since the goal of BTK angioplasty is to maximize distal flow in order to heal wounds, recoil is a significant problem. As a result, reducing the incidence of acute recoil should be an important goal in improving BTK treatment.
Topics: Peripheral IVL, Peripheral Clinical Data, Shockwave S4
It’s that time of year where there seems to be a countdown for everything – Top 100 Songs, Top Baby Names, Top 10 Sports Moments of 2019 – We wanted to get in on the fun too and here it is… Top 5 Peripheral IVL Publications from 2019!
Topics: Peripheral Clinical Data
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
